Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Jim Kling

    News

    Social Adversity Increases Mortality Risk in Patients With Pulmonary Hypertension

    Author:
    Jim Kling
    Publish date: November 4, 2024

    HIV+ patients with HF, PH, and social adversity had a sevenfold increase in all-cause mortality.

    • Read More

    News

    Digital Twin Model Predicts Sepsis Mortality

    Author:
    Jim Kling
    Publish date: November 4, 2024

    A “digital twin” model predicted adverse outcomes in ICU patients treated for sepsis.

    • Read More

    News

    ILD Linked to Poorer Outcomes in Pulmonary Embolism

    Author:
    Jim Kling
    Publish date: October 9, 2024

    PE and ILD linked to increased mortality while in hospital, length of stay, readmission,and costs.

    • Read More

    News

    Use of SGLT2 Inhibitors Associated With Better Survival in PAH

    Author:
    Jim Kling
    Publish date: October 9, 2024

    SGLT2i use improved both short- and long-term survival for those with PAH, study finds.

    • Read More

    News

    Hospitalized Patients With COPD and GERD Have Better Short-Term Outcomes

    Author:
    Jim Kling
    Publish date: October 9, 2024

    GERD is linked to better outcomes for patients in the hospital with COPD, though were at higher risk for readmission.

    • Read More

    News

    In Crohn’s Disease, Early Anti-TNF Levels May be Crucial

    Author:
    Jim Kling
    Publish date: October 3, 2024

    “Getting it right in induction is probably the most important part” of treating Crohn’s disease, said Dr. Miguel Regueiro.

    • Read More

    News

    Nasal Staph Aureus Carriage Linked to Surgical Infections

    Author:
    Jim Kling
    Publish date: September 26, 2024

    A large prospective study suggests that nasal decolonization could be a simple intervention to reduce surgical site and blood infections.

    • Read More

    News

    Study Finds Differences in Side Effect Profiles With Two Oral Psoriasis Therapies

    Author:
    Jim Kling
    Publish date: July 26, 2024

    The results were based on data from the FDA’s Adverse Event Reporting System.

    • Read More

    News

    Risk of MACE Comparable Among Biologic Classes for Psoriasis, PsA

    Author:
    Jim Kling
    Publish date: July 26, 2024

    Despite some concern about increased risk for MACE with TNFi use, this study suggests no special risk for patients with psoriasis or PsA...

    • Read More

    News

    Mysteries Persist About Tissue Resident Memory T Cells in Psoriasis

    Author:
    Jim Kling
    Publish date: July 25, 2024

    These cells reside in the skin and other tissues and promote the inflammatory response, likely contributing to psoriasis symptoms.

    • Read More

    News

    Debate: Should Dermatologists or Rheumatologists Manage Musculoskeletal Symptoms in Patients With Psoriasis?

    Author:
    Jim Kling
    Publish date: July 23, 2024

    The rheumatologist emphasized the potential that MSK symptoms are a sign of psoriatic arthritis and therefore should be managed by a...

    • Read More

    News

    Eptinezumab Inhibitor Fails Cluster Headache Test

    Author:
    Jim Kling
    Publish date: July 1, 2024

    Failed primary but successful secondary measures hints that it might be time for a change in cluster headache clinical trial endpoints.

    • Read More

    News

    Migraine Linked to Cardiovascular Risk in Veterans Study

    Author:
    Jim Kling
    Publish date: June 24, 2024

    A Veterans Administration study of migraine found a greater risk of stroke and TIA and a reduced risk of hemorrhagic stroke in men.

    • Read More

    News

    New Survey Explores New Daily Persistent Headache

    Author:
    Jim Kling
    Publish date: June 21, 2024

    Patient responses suggest CGRP inhibitors might be a good preventative, and that many experience brain fog.

    • Read More

    News

    Lidocaine Effective Against Pediatric Migraine

    Author:
    Jim Kling
    Publish date: June 18, 2024

    The first randomized, controlled trial confirms observational studies and could pave the way for insurance coverage.

    • Read More

    Pages

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery